By targeting multiple mechanismssuch as enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satietyGLP-1 RAs provide significant improvements in glycemic control, weight reduction, and long-term cardiovascular and renal health (6)(16)(23)
This dual-action approach not only helps regulate hunger but also boosts insulin sensitivity, making it a great fit for those seeking enhanced weight loss support and improved metabolic health
102 Hence, insulin indirectly reduces gastrointestinal motility, appetite and gastric acid secretion due to its suppression of ghrelin
The goal is to find the minimum effective dose
Research indicated that Exendin-4 treatment increased cAMP levels, reduced Na + /K + ATPase activity, and modulated the GLP-1 receptor in the rat choroid plexus in vitro ( Recent findings also suggest that GLP-1 modulates the SIRT1 pathway, which plays a crucial role in regulating inflammation and autophagy
doi:10.1002/ajmg.c.30087